The Efficacy and Safety of Shashen-Maidong Decoction Combined with Western Medicine in the Treatment of Omicron Infected Individuals Over 85 Years Old: A Retrospective Study

References

• Ross JA, Malone PK, Levy S. The impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic on substance use in the United States. Clin Infect Dis. 2022;75(Supplement_1):S81–S85. doi:10.1093/cid/ciac311
   PubMedGoogle Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239–1242. doi:10.1001/jama.2020.2648
   PubMed Web of Science ®Google Scholar
• Vitiello A, Ferrara F, Auti AM, Di Domenico M, Boccellino M. Advances in the omicron variant development. J Intern Med. 2022;292(1):81–90. doi:10.1111/joim.13478
   PubMed Web of Science ®Google Scholar
• Chavda VP, Apostolopoulos V. Omicron variant (B.1.1.529) of SARS-CoV-2: threat for the elderly? Maturitas. 2022;158:78–81. doi:10.1016/j.maturitas.2022.01.011
   PubMed Web of Science ®Google Scholar
• Peng Y, Guo Y, Zhang H, et al. Clinical characteristics and analysis of risk factors for disease progression of patients with SARS-CoV-2 omicron variant infection: a retrospective study of 25,207 cases in a Fangcang hospital. Front Cell Infect Microbiol. 2022;12:1009894. doi:10.3389/fcimb.2022.1009894
   PubMed Web of Science ®Google Scholar
• Bai Y, Shao Z, Zhang X, et al. Reproduction number of SARS-CoV-2 omicron variants, China, December 2022-January 2023. arXiv preprint arXiv. 2023;2303:10642.
   Google Scholar
• Cai C, Li Y, Hu T, et al. The associated factors of SARS-CoV-2 reinfection by omicron variant—Guangdong Province, China, December 2022 to January 2023. China CDC Weekly. 2023;5(18):391–392. doi:10.46234/ccdcw2023.075
   PubMedGoogle Scholar
• National Health Commission of the People’s Republic of China. Novel coronavirus pneumonia diagnosis and treatment plan (provisional 10th ed); 2023. Available from: https://www.gov.cn/zhengce/zhengceku/2023-01/06/5735343/files/5844ce04246b431dbd322d8ba10afb48.pdf. Accessed November 23, 2023.
   Google Scholar
• Duan N, Liu B, Li X, et al. Traditional Chinese medicine in treating children with coronavirus disease 2019: a scoping review. Front Pediatr. 2022;10:935551. doi:10.3389/fped.2022.935551
   PubMed Web of Science ®Google Scholar
• Ni L, Chen L, Huang X, et al. Combating COVID-19 with integrated traditional Chinese and Western medicine in China. Acta Pharmaceutica Sinica B. 2020;10(7):1149–1162. doi:10.1016/j.apsb.2020.06.008
   PubMed Web of Science ®Google Scholar
• Xin S, Cheng X, Zhu B, et al. Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment. Biomed Pharmacother. 2020;129:110500. doi:10.1016/j.biopha.2020.110500
   PubMed Web of Science ®Google Scholar
• Feng C, Wenlin Y, Qiangyong K, et al. Clinical efficacy of combination therapy of FuXi-Tiandi-Wuxing decoction and anti-viral drugs in the treatment of novel coronavirus pneumonia: a prospective interventional study. J Herb Med. 2023;38:100627. doi:10.1016/j.hermed.2022.100627
   PubMed Web of Science ®Google Scholar
• Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422. doi:10.1016/S2213-2600(20)30076-X
   PubMed Web of Science ®Google Scholar
• Xiong WZ, Wang G, Du J, Ai W. Efficacy of herbal medicine (Xuanfei Baidu decoction) combined with conventional drug in treating COVID-19: a pilot randomized clinical trial. Integr Med Res. 2020;9(3):100489. doi:10.1016/j.imr.2020.100489
   PubMed Web of Science ®Google Scholar
• He M, Luo Y, Chen L, et al. Shashen maidong decoction: the effect of TNF-α and IL-6 on lung cancer cachexia based on cancer toxicity theory. Am J Transl Res. 2021;13(6):6752.
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhou Y. Shashen-maidong decoction-mediated IFN-γ and IL-4 on the regulation of Th1/Th2 imbalance in RP rats. Biomed Res Int. 2019;2019:1.
   Web of Science ®Google Scholar
• Hu CS. Analysis of COVID-19 cases and public measures in China. SN Compr Clin Med. 2020;2:1306–1312. doi:10.1007/s42399-020-00426-6
   PubMedGoogle Scholar
• Hu CS. Emergency protective measures and strategies of COVID-19: from lifestyle to traditional Chinese medicine. Clin Compl Med Pharmacol. 2023;3(3):2772–3712. doi:10.1016/j.ccmp.2023.100089
   Google Scholar
• Shi SF, Fang ZY, Xiong K, et al. Clinical studies of comprehensive TCM treatment to 30 cases of Qi Yin deficiency type of COVID-19 in its recovery period. Jiangsu J Tradit Chin Med. 2021;53(1):4.
   Google Scholar
• Gray PE, Belessis Y. The use of traditional Chinese medicines to treat SARS-CoV-2 may cause more harm than good. Pharmacol Res. 2020;156:104776. doi:10.1016/j.phrs.2020.104776
   PubMed Web of Science ®Google Scholar
• Wang Y, Gao D, Li X, et al. Early changes in laboratory tests predict liver function damage in patients with moderate coronavirus disease 2019: a retrospective multicenter study. BMC Gastroenterol. 2022;22(1):113. doi:10.1186/s12876-022-02188-y
   PubMed Web of Science ®Google Scholar
• Tseng YH, Lin SJ, Hou SM, et al. Curbing COVID-19 progression and mortality with traditional Chinese medicine among hospitalized patients with COVID-19: a propensity score-matched analysis. Pharmacol Res. 2022;184:106412. doi:10.1016/j.phrs.2022.106412
   PubMed Web of Science ®Google Scholar
• Yao CL, Wei WL, Zhang JQ, et al. Traditional Chinese medicines against COVID-19: a global overview. World J Tradit Chin Med. 2022;8:279–313. doi:10.4103/2311-8571.353502
   Google Scholar
• Li L, Xie H, Wang L, et al. The efficacy and safety of combined Chinese herbal medicine and Western medicine therapy for COVID-19: a systematic review and meta-analysis. Chin Med. 2022;17(1):77. doi:10.1186/s13020-022-00600-z
   PubMed Web of Science ®Google Scholar
• Song ZJ, Nik Nabil WN, Xi ZC, Xu HX. Current global status and future development of traditional Chinese medicine in the prevention and treatment of coronavirus disease 2019. World J Tradit Chin Med. 2021;7:155–166.
   Google Scholar
• Li MX, Yang YY, Liu Y, et al. Progress of traditional Chinese medicine treating COVID-19. World J Tradit Chin Med. 2021;7:167–183.
   Google Scholar
• Yu R, Zhang S, Zhao D, Yuan Z. A systematic review of outcomes in COVID-19 patients treated with Western medicine in combination with traditional Chinese medicine versus Western medicine alone. Expert Rev Mol Med. 2022;24:e5. doi:10.1017/erm.2021.35
   PubMed Web of Science ®Google Scholar
• Dehghan M, Ghanbari A, Heidari FG, Shahrbabaki PM, Zakeri MA. Use of complementary and alternative medicine in general population during COVID-19 outbreak: a survey in Iran. J Integr Med. 2022;20(1):45–51. doi:10.1016/j.joim.2021.11.004
   PubMedGoogle Scholar